Vascular risk factors increase the risk of developing Alzheimer's disease. Increased
concentrations of circulating homocysteine are associated with an increased risk of both …

Increased circulating concentrations of homocysteine may be a risk factor for Alzheimer's
disease and cognitive dysfunction in normal aging. Asymmetric dimethylarginine (ADMA) is …

To investigate the significance of nitric oxide (NO)-mediated neuron death in aging and
Alzheimer's disease (AD), the concentration of asymmetrical dimethylarginine (ADMA), an …

Background: Asymmetrical dimethylarginine (ADMA) is an endogenous inhibitor of nitric
oxide (NO) synthase and may alter NO production during pathological conditions …

Dimethylarginine and homocysteine metabolism are closely linked and alterations of both
were observed in plasma and cerebrospinal fluid (CSF) of patients with Alzheimer's disease …

Nitric oxide is involved in normal physiological functions and also in pathological processes
leading to tissue damage due, in part, to its free radical nature (oxidative stress). Oxidative …

There is evidence that increased blood concentrations of homocysteine may be a risk factor
for Alzheimer's disease.(E)-4-hydroxy-2-nonenal (HNE) is a neurotoxic product of lipid …

Repetitive measurement with neuroimaging techniques could be useful instruments
permitting to differentiate between Alzheimer disease (AD) and vascular dementia (VD). The …

There is good epidemiological evidence that vascular disease predisposes to cognitive
decline and dementia. The impact of vascular disease on dementia is likely to increase …

Cerebrovascular risk factors, including hypertension, smoking, diabetes mellitus, aging,
dyslipidemia, and hyperhomocyst (e) inemia are linked to endothelial dysfunction …